CA2417336A1 - Procede pour reduire les exacerbations associees a la bpco - Google Patents
Procede pour reduire les exacerbations associees a la bpco Download PDFInfo
- Publication number
- CA2417336A1 CA2417336A1 CA002417336A CA2417336A CA2417336A1 CA 2417336 A1 CA2417336 A1 CA 2417336A1 CA 002417336 A CA002417336 A CA 002417336A CA 2417336 A CA2417336 A CA 2417336A CA 2417336 A1 CA2417336 A1 CA 2417336A1
- Authority
- CA
- Canada
- Prior art keywords
- copd
- exacerbations
- patients
- exacerbation
- placebo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Cette invention se rapporte à un procédé servant à réduire les incidences et/ou la gravité des exacerbations de la broncho-pneumopathie chronique obstructive (BPCO), en administrant un inhibiteur de phosphodiestérase 4 (PDE4).
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22127500P | 2000-07-27 | 2000-07-27 | |
| US60/221,275 | 2000-07-27 | ||
| PCT/US2001/023542 WO2002009689A1 (fr) | 2000-07-27 | 2001-07-26 | Procede pour reduire les exacerbations associees a la bpco |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2417336A1 true CA2417336A1 (fr) | 2002-02-07 |
Family
ID=22827112
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002417336A Abandoned CA2417336A1 (fr) | 2000-07-27 | 2001-07-26 | Procede pour reduire les exacerbations associees a la bpco |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1320361A4 (fr) |
| JP (1) | JP2004505039A (fr) |
| KR (1) | KR20030019620A (fr) |
| CN (1) | CN1444476A (fr) |
| AR (1) | AR029984A1 (fr) |
| AU (2) | AU7902301A (fr) |
| BR (1) | BR0112682A (fr) |
| CA (1) | CA2417336A1 (fr) |
| CZ (1) | CZ2003141A3 (fr) |
| HU (1) | HUP0300685A3 (fr) |
| IL (1) | IL153919A0 (fr) |
| MX (1) | MXPA03000714A (fr) |
| NO (1) | NO20030332D0 (fr) |
| PL (1) | PL365612A1 (fr) |
| WO (1) | WO2002009689A1 (fr) |
| ZA (1) | ZA200300476B (fr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2165768B1 (es) | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen. |
| US7776315B2 (en) | 2000-10-31 | 2010-08-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions based on anticholinergics and additional active ingredients |
| DE10110772A1 (de) * | 2001-03-07 | 2002-09-12 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und PDE-IV-Inhibitoren |
| GB0118373D0 (en) * | 2001-07-27 | 2001-09-19 | Glaxo Group Ltd | Novel therapeutic method |
| MY140561A (en) | 2002-02-20 | 2009-12-31 | Nycomed Gmbh | Dosage form containing pde 4 inhibitor as active ingredient |
| DE10230769A1 (de) * | 2002-07-09 | 2004-01-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und PDE-IV-Inhibitoren |
| ME00524B (me) | 2003-03-10 | 2011-10-10 | Astrazeneca Ab | Novi postupak za dobijanje roflumilasta |
| EP2100599A1 (fr) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Composition à inhaler comprenant aclidinium pour le traitement de l'asthme et de maladies respiratoires obstructives chroniques |
| EP2100598A1 (fr) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Composition à inhaler comprenant aclidinium pour le traitement de l'asthme et de maladies respiratoires obstructives chroniques |
| EP2510928A1 (fr) | 2011-04-15 | 2012-10-17 | Almirall, S.A. | Aclidinium pour l'amélioration du sommeil des patients avec des maldadies respiratoires |
| KR102087661B1 (ko) * | 2018-07-27 | 2020-03-11 | 강원대학교산학협력단 | Ｇｅｂｒ―７ｂ 화합물을 유효성분으로 포함하는 만성폐쇄성 폐질환의 예방 또는 치료용 조성물 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DZ3019A1 (fr) * | 1999-03-01 | 2005-05-20 | Smithkline Beecham Corp | Utilisation d'un inhibiteur de pde4 dans la préparation d'un médicament contre la copd. |
| SE9902937D0 (sv) * | 1999-08-18 | 1999-08-18 | Astra Pharma Prod | Pharmaceutical compositions |
| DZ3249A1 (fr) * | 1999-10-29 | 2001-05-10 | Smithkline Beecham Corp | Procédé d'administration d'un inhibiteur phosphodiesterase 4 |
-
2001
- 2001-07-25 AR ARP010103546A patent/AR029984A1/es not_active Application Discontinuation
- 2001-07-26 EP EP01957262A patent/EP1320361A4/fr not_active Withdrawn
- 2001-07-26 CN CN01813330A patent/CN1444476A/zh active Pending
- 2001-07-26 AU AU7902301A patent/AU7902301A/xx active Pending
- 2001-07-26 BR BR0112682-2A patent/BR0112682A/pt not_active IP Right Cessation
- 2001-07-26 JP JP2002515242A patent/JP2004505039A/ja not_active Withdrawn
- 2001-07-26 KR KR10-2003-7001144A patent/KR20030019620A/ko not_active Application Discontinuation
- 2001-07-26 CA CA002417336A patent/CA2417336A1/fr not_active Abandoned
- 2001-07-26 PL PL01365612A patent/PL365612A1/xx not_active Application Discontinuation
- 2001-07-26 WO PCT/US2001/023542 patent/WO2002009689A1/fr not_active Application Discontinuation
- 2001-07-26 AU AU2001279023A patent/AU2001279023B2/en not_active Ceased
- 2001-07-26 CZ CZ2003141A patent/CZ2003141A3/cs unknown
- 2001-07-26 MX MXPA03000714A patent/MXPA03000714A/es unknown
- 2001-07-26 IL IL15391901A patent/IL153919A0/xx unknown
- 2001-07-26 HU HU0300685A patent/HUP0300685A3/hu unknown
-
2003
- 2003-01-17 ZA ZA200300476A patent/ZA200300476B/en unknown
- 2003-01-22 NO NO20030332A patent/NO20030332D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20030019620A (ko) | 2003-03-06 |
| AR029984A1 (es) | 2003-07-23 |
| CZ2003141A3 (cs) | 2004-07-14 |
| IL153919A0 (en) | 2003-07-31 |
| EP1320361A1 (fr) | 2003-06-25 |
| AU7902301A (en) | 2002-02-13 |
| HUP0300685A3 (en) | 2004-10-28 |
| NO20030332L (no) | 2003-01-22 |
| AU2001279023B2 (en) | 2005-11-10 |
| HUP0300685A2 (hu) | 2003-12-29 |
| BR0112682A (pt) | 2003-06-24 |
| NO20030332D0 (no) | 2003-01-22 |
| JP2004505039A (ja) | 2004-02-19 |
| MXPA03000714A (es) | 2003-06-04 |
| ZA200300476B (en) | 2004-04-23 |
| WO2002009689A1 (fr) | 2002-02-07 |
| EP1320361A4 (fr) | 2006-04-05 |
| CN1444476A (zh) | 2003-09-24 |
| PL365612A1 (en) | 2005-01-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20060069155A1 (en) | Method for reducing exacerbations associated with COPD | |
| JP4097285B2 (ja) | 種々の頑固な疾患の治療のための医薬の製造に有用な組成物 | |
| JP2004531468A5 (fr) | ||
| AU2001279023B2 (en) | Method for reducing exacerbations associated with COPD | |
| AU2001279023A1 (en) | Method for reducing exacerbations associated with COPD | |
| AU772909B2 (en) | Method for administering a phosphodiesterase 4 inhibitor | |
| US20030211152A1 (en) | Controlled release formulation for treating COPD | |
| TWI242431B (en) | Pharmaceutical compositions for treating pulmonary diseases | |
| US20060035877A1 (en) | Method and compositions for treating pulmonary diseases | |
| US6713509B1 (en) | Controlled release formulation for treating COPD | |
| JPH06500129A (ja) | ヌクレオシド誘導体 | |
| JP2014527513A (ja) | 早漏症治療用の薬学組成物および早漏症治療方法 | |
| MXPA06010598A (es) | Composicion farmaceutica de (+) -eritro-mefloquina y su uso. | |
| JP2005533870A (ja) | アバカビールおよびアロブジンの相乗的相互作用 | |
| CN112203658A (zh) | 包含卓匹非索和塞尼韦洛的组合 | |
| AU2004205324A1 (en) | Method and compositions for treating pulmonary diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |